Therefore, our results suggest that SIRT6 is involved in the progression of ovarian carcinomas and that inhibition of SIRT6 might be a new therapeutic stratagem for the treatment of ovarian cancers, especially in the cancers with high expression of SIRT6. The gene discussed is SIRT6; the disease is ovarian cancer.